The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer
出版年份 2020 全文链接
标题
The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer
作者
关键词
-
出版物
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-23
DOI
10.1038/s41418-020-0538-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Breaking the chains: deubiquitylating enzyme specificity begets function
- (2019) Michael J. Clague et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
- (2019) Jinrui Zhang et al. Cell Communication and Signaling
- The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms
- (2018) Taishu Wang et al. Cell Communication and Signaling
- Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
- (2018) Funda Meric-Bernstam et al. CLINICAL CANCER RESEARCH
- The HSP90 chaperone machinery
- (2017) Florian H. Schopf et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction
- (2016) John J.M. Bergeron et al. Annual Review of Biochemistry
- Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
- (2016) W.-J. Zuo et al. CLINICAL CANCER RESEARCH
- Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
- (2016) Mindy I. Davis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting HER2 for the Treatment of Breast Cancer
- (2015) Mothaffar F. Rimawi et al. Annual Review of Medicine
- The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOLNovelty and Significance
- (2015) Jessica Kristine Nelson et al. CIRCULATION RESEARCH
- HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors
- (2015) D. A. Proia et al. MOLECULAR CANCER THERAPEUTICS
- Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
- (2014) Komal Jhaveri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Deubiquitylases From Genes to Organism
- (2013) Michael J. Clague et al. PHYSIOLOGICAL REVIEWS
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
- (2012) Dharminder Chauhan et al. CANCER CELL
- A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors
- (2012) K. Jhaveri et al. CLINICAL CANCER RESEARCH
- Governance of Endocytic Trafficking and Signaling by Reversible Ubiquitylation
- (2012) Michael J. Clague et al. DEVELOPMENTAL CELL
- The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments
- (2012) Katia Cortese et al. MOLECULAR BIOLOGY OF THE CELL
- The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation
- (2012) Z Liu et al. ONCOGENE
- Endocytosis and Signaling: Cell Logistics Shape the Eukaryotic Cell Plan
- (2012) Sara Sigismund et al. PHYSIOLOGICAL REVIEWS
- A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication
- (2012) Dilip K. Nag et al. VIRUS RESEARCH
- Targeting Hsp90 prevents escape of breast cancer cells from tyrosine kinase inhibition
- (2011) Itai Pashtan et al. CELL CYCLE
- HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
- (2011) S. Modi et al. CLINICAL CANCER RESEARCH
- Deubiquitylating enzyme USP2 counteracts Nedd4-2–mediated downregulation of KCNQ1 potassium channels
- (2011) Katarzyna Krzystanek et al. HEART RHYTHM
- Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting
- (2011) Verónica Alonso et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Feedback regulation of EGFR signalling: decision making by early and delayed loops
- (2011) Roi Avraham et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib
- (2011) Rama Krishna Kancha et al. PLoS One
- ErbB2 Trafficking and Degradation Associated with K48 and K63 Polyubiquitination
- (2010) Corina Marx et al. CANCER RESEARCH
- Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer
- (2010) Anna Emde et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib
- (2009) C. C. Leow et al. MOLECULAR CANCER THERAPEUTICS
- Suppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation
- (2009) Jing Shan et al. MOLECULAR CELL
- Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
- (2009) S Chandarlapaty et al. ONCOGENE
- EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation
- (2008) T. Trowe et al. CLINICAL CANCER RESEARCH
- Endocytosis and intracellular trafficking of ErbBs
- (2008) Alexander Sorkin et al. EXPERIMENTAL CELL RESEARCH
- Deubiquitylation Regulates Activation and Proteolytic Cleavage of ENaC
- (2008) D. Ruffieux-Daidie et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Geldanamycin-Induced Down-Regulation of ErbB2 from the Plasma Membrane Is Clathrin Dependent but Proteasomal Activity Independent
- (2008) N. M. Pedersen et al. MOLECULAR CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More